TCI Wealth Advisors, Inc. - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 180 filers reported holding FATE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$5,993
-25.1%
594
+61.0%
0.00%0.0%
Q3 2022$8,000
+14.3%
369
+30.9%
0.00%0.0%
Q2 2022$7,000
+16.7%
282
+88.0%
0.00%0.0%
Q1 2022$6,000
-75.0%
150
-63.0%
0.00%
-75.0%
Q4 2021$24,000
+20.0%
405
+17.7%
0.00%
+33.3%
Q3 2021$20,000
-9.1%
344
+33.3%
0.00%
-25.0%
Q2 2021$22,000
-53.2%
258
-55.0%
0.00%
-80.0%
Q1 2021$47,000
+4.4%
573
+14.6%
0.02%0.0%
Q4 2020$45,000
+40.6%
500
-37.5%
0.02%
+53.8%
Q3 2020$32,000
+14.3%
800
-3.0%
0.01%
+8.3%
Q2 2020$28,000
+55.6%
8250.0%0.01%
+33.3%
Q1 2020$18,0000.0%825
-10.8%
0.01%
+28.6%
Q4 2019$18,000
-14.3%
925
-30.2%
0.01%
-22.2%
Q3 2019$21,000
-27.6%
1,325
-7.0%
0.01%
-30.8%
Q2 2019$29,000
+16.0%
1,4250.0%0.01%
+18.2%
Q1 2019$25,000
+13.6%
1,425
-17.4%
0.01%0.0%
Q4 2018$22,000
-15.4%
1,725
+6.2%
0.01%0.0%
Q3 2018$26,000
+30.0%
1,625
-5.8%
0.01%
+22.2%
Q2 2018$20,000
+25.0%
1,725
+6.2%
0.01%
+28.6%
Q1 2018$16,000
+77.8%
1,625
+6.6%
0.01%
+75.0%
Q4 2017$9,000
+50.0%
1,525
-4.7%
0.00%
+33.3%
Q3 2017$6,000
+100.0%
1,600
+100.0%
0.00%
+50.0%
Q2 2017$3,000
+50.0%
800
+60.0%
0.00%
+100.0%
Q1 2017$2,000
+100.0%
5000.0%0.00%0.0%
Q4 2016$1,0005000.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$131,006,00024.77%
Redmile Group, LLC 12,957,222$502,351,00015.68%
Grosvenor Holdings, L.L.C. 1,037,256$40,214,0007.85%
Casdin Capital, LLC 3,400,000$131,818,0005.91%
Ally Bridge Group (NY) LLC 181,500$7,037,0005.22%
DAFNA Capital Management LLC 500,930$19,421,0005.06%
Deep Track Capital, LP 2,000,000$77,540,0004.97%
Artal Group S.A. 2,000,000$77,540,0003.25%
Tri Locum Partners LP 190,345$7,380,0002.88%
ARK Investment Management 10,988,182$426,012,0001.78%
View complete list of FATE THERAPEUTICS INC shareholders